tiprankstipranks
Trending News
More News >
Autolus Therapeutics Plc (AUTL)
NASDAQ:AUTL
US Market

Autolus Therapeutics (AUTL) Financial Statements

Compare
865 Followers

Autolus Therapeutics Financial Overview

Autolus Therapeutics's market cap is currently $508.33M. The company's EPS TTM is $-0.3; its P/E ratio is -2.26; Autolus Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 10.12M$ 1.70M$ 6.19M$ 1.51M$ 1.72M
Gross Profit$ -130.90M$ 1.70M$ 6.19M$ 1.51M$ -133.17M
Operating Income$ -241.43M$ -179.70M$ -142.89M$ -140.37M$ -303.13M
EBITDA$ -233.07M$ -156.77M$ -132.24M$ -132.47M$ -162.58M
Net Income$ -220.66M$ -208.38M$ -148.84M$ -142.10M$ -142.09M
Balance Sheet
Cash & Short-Term Investments$ 588.02M$ 239.57M$ 382.44M$ 310.34M$ 154.09M
Total Assets$ 782.73M$ 375.38M$ 490.27M$ 405.56M$ 294.24M
Total Debt$ 52.63M$ 52.97M$ 24.26M$ 68.01M$ 54.16M
Net Debt$ -174.75M$ -186.60M$ -358.18M$ -242.32M$ -99.92M
Total Liabilities$ 355.40M$ 263.91M$ 191.60M$ 92.24M$ 84.20M
Stockholders' Equity$ 427.32M$ 111.47M$ 298.67M$ 313.32M$ 210.03M
Cash Flow
Free Cash Flow$ -241.09M$ -156.57M$ -123.15M$ -126.72M$ -132.44M
Operating Cash Flow$ -206.27M$ -145.59M$ -112.31M$ -117.86M$ -117.76M
Investing Cash Flow$ -394.55M$ -10.99M$ -10.84M$ -8.86M$ -14.68M
Financing Cash Flow$ 589.55M$ -883.00K$ 223.61M$ 284.06M$ 74.42M
Currency in USD

Autolus Therapeutics Earnings and Revenue History

Autolus Therapeutics Debt to Assets

Autolus Therapeutics Cash Flow

Autolus Therapeutics Forecast EPS vs Actual EPS